Back to 
Hudson Bay Capital Management LP
Hudson Bay Capital Management LP
BCTXShowing 0 of 2 quarters
Position history for Hudson Bay Capital Management LP's holdings in BRIACELL THERAPEUTICS CORP
No. Hudson Bay Capital exited its BCTX (Briacell Therapeutics) position in Q3 2021. Its Q2 2021 13F listed 400,000 shares worth $2.1M. Hudson Bay Capital first reported BCTX in Q2 2021 and held it in 1 quarterly 13F filing.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of BCTX: WASATCH ADVISORS LP